Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.
about
Role of "old" pharmacological agents in the treatment of Cushing's syndromeUpdate on medical treatment for Cushing's disease.Cushing's syndrome: an update on current pharmacotherapy and future directions.Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New NomenclatureDopamine Agonists for Pituitary Adenomas
P2860
Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Preoperative normalization of ...... analogs and dopamine agonists.
@en
Preoperative normalization of ...... analogs and dopamine agonists.
@nl
type
label
Preoperative normalization of ...... analogs and dopamine agonists.
@en
Preoperative normalization of ...... analogs and dopamine agonists.
@nl
prefLabel
Preoperative normalization of ...... analogs and dopamine agonists.
@en
Preoperative normalization of ...... analogs and dopamine agonists.
@nl
P2093
P50
P356
P1476
Preoperative normalization of ...... analogs and dopamine agonists
@en
P2093
A M Waaijers
C de Bruin
D M Sprij-Mooij
L J Hofland
P M van Koetsveld
R A Feelders
R van der Pas
S W J Lamberts
P304
P356
10.1210/JC.2013-1987
P407
P577
2013-09-30T00:00:00Z